Enhancement of supplement management system for crchd provided by MDB INC:1108559 [19-061869]
Ended Awarded
- Contract number
- 75N91019F00133
- Awardee
-
Mdb, Inc. UEI J4KLUDGBKYJ7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $71,760
Award facts
- Contract value 100% obligated
- $71,760.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Washington, DC 20036, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute (NCI) awarded a $71.76K firm fixed-price BPA call to MDB Inc., doing business as Michael D. Baker Inc., on September 3, 2019, for the enhancement of the Supplement Management System for the Cancer Research Centers for Health Disparities (CRCHD). The award was executed without a set-aside designation and originated under the Professional Services Schedule (PSS) on the General Services Administration (GSA). Performance was completed by September 5, 2020, in Washington, DC.
MDB Inc., a small business federal contractor based in Washington, DC, and registered in SAM since 2003, brings substantial experience delivering professional services to the National Institutes of Health and affiliated agencies. The company has demonstrated expertise across research support, technical communications, and administrative consulting domains, supported by multiple significant IDVs and BPAs, including a $9.7M Technical, Logistics, and Administrative Support BPA with the National Institute of Environmental Health Sciences. This engagement with NCI leverages the contractor's established capability to provide specialized technical and administrative support services critical to advancing the Institute's research and operational objectives.
Quick answers
Who was awarded contract 75N91019F00133?
75N91019F00133 was awarded to Mdb, Inc. by National Cancer Institute (National Institutes of Health) on September 3, 2019.
How much is contract 75N91019F00133 worth?
The government has obligated $71,760 on 75N91019F00133.
Is contract 75N91019F00133 an order under another contract?
Yes. 75N91019F00133 is a BPA call under GS00F0001S-HHSN263201000141B, a blanket purchase agreement, on The Professional Services Schedule (PSS).
Was contract 75N91019F00133 competed?
The extent of competition for 75N91019F00133 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award